Form 4: Encompass Health CFO Douglas Coltharp Reports Stock Transaction

Encompass Health's EVP and Chief Financial Officer, Douglas Coltharp, reported a transaction involving the withholding of 12,438 shares to cover tax obligations.

Summary

• Douglas Coltharp, the EVP & Chief Financial Officer of Encompass Health Corp, filed a Form 4 detailing a transaction on January 1, 2025.
• The transaction involved the withholding of 12,438 shares of Encompass Health common stock to cover tax obligations related to the vesting of restricted stock.
• The shares were withheld at a price of $92.35 per share.
• Following the transaction, Coltharp directly owns 58,560 shares of Encompass Health common stock.
• He also indirectly owns 125,631 shares through an irrevocable trust for the benefit of his children and 65,229 shares through his spouse.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a standard transaction. It does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to insider transactions and is common for executives who receive stock-based compensation. It does not indicate any specific trend or issue within the healthcare industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical executive compensation practices.
• Similar filings are regularly made by executives at comparable healthcare companies such as HCA Healthcare and Tenet Healthcare.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine tax withholding event.

Key Dates

Keywords

Form 4, insider trading, stock transaction, Encompass Health, Douglas Coltharp, EHC, CFO, tax withholding, share ownership